Tailored Treatment Dosing for Older Adults with Cancer
Part of Cancer clinical trials.
This trial tests a new dosing strategy (called TRTRM or ACTTOP) to find the right amount of cancer treatment for patients aged 65 and older. It aims to reduce side effects while keeping the treatment effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years old or older.
- You have one of these cancers: lung, stomach/intestinal, breast, prostate, or uterine cancer.
- You are about to start a new cancer treatment (chemotherapy, targeted therapy, or immunotherapy) that is expected to last at least 3 months.
- You are able to carry out daily activities without significant help (ECOG score 0-2).
- You speak English or Chinese and can give consent.
- You are not scheduled for radiation therapy alone, or surgery within the next 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether adding special geriatric (older-adult) care to standard cancer treatment helps older patients manage their health better. The goal is to improve quality of life and reduce treatment complications.
This trial tests whether remote health assessments and support can improve care for adults 65+ who are starting a new cancer treatment. You'd participate from home via telehealth visits.
This trial is testing whether adjusting the dose of a targeted therapy (CDK 4/6 inhibitor) based on a geriatric assessment can be as effective and safer for people aged 70 and older with advanced hormone receptor-positive, HER2-negative breast cancer. It aims to find the best dose to balance benefits and side effects.
This trial tests a targeted radiation therapy approach for adults aged 75 and older whose cancer has advanced and standard treatments have stopped working or are not suitable. The goal is to see if this precise radiation can control the tumor with fewer side effects.
This trial tests two different treatment strategies for older adults with rectal cancer that hasn't spread. The goal is to find which approach works better and is safer for people in this age group.
This study tests a new way of giving radiation therapy in smaller, more frequent doses along with your first round of systemic treatment (chemo or other drugs) for metastatic colorectal cancer. The goal is to find a treatment that is effective and easier for older or frailer patients to tolerate.
Hear when a new Geriatric Oncology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.